🚀 VC round data is live in beta, check it out!
Redcare Pharmacy Valuation Multiples
Discover revenue and EBITDA valuation multiples for Redcare Pharmacy and similar public comparables like Anhui Huaren Health, Aldawaa Medical Services, Medplus Health Services, Selçuk Ecza and more.
Redcare Pharmacy Overview
About Redcare Pharmacy
Redcare Pharmacy NV operates an online pharmacy store. Its product portfolio is focused on prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products. The company's operating segment includes DACH and International. It generates maximum revenue from the DACH segment, which represents income generated from Germany, Austria, and Switzerland. The International segment represents its income generated from Belgium, the Netherlands, France, and Italy.
Founded
2015
HQ
Employees
2.7K
Website
Sectors
Financials (LTM)
EV
$1B
Redcare Pharmacy Financials
Redcare Pharmacy reported last 12-month revenue of $4B and EBITDA of $77M.
In the same LTM period, Redcare Pharmacy generated $805M in gross profit, $77M in EBITDA, and had net loss of ($37M).
Revenue (LTM)
Redcare Pharmacy P&L
In the most recent fiscal year, Redcare Pharmacy reported revenue of $3B and EBITDA of $67M.
Redcare Pharmacy expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | $805M | XXX | $781M | XXX | XXX | XXX |
| Gross Margin | 23% | XXX | 23% | XXX | XXX | XXX |
| EBITDA | $77M | XXX | $67M | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| EBIT Margin | (0%) | XXX | (1%) | XXX | XXX | XXX |
| Net Profit | ($37M) | XXX | ($44M) | XXX | XXX | XXX |
| Net Margin | (1%) | XXX | (1%) | XXX | XXX | XXX |
| Net Debt | — | — | $290M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Redcare Pharmacy Stock Performance
Redcare Pharmacy has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
Redcare Pharmacy's stock price is $57.83.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | 8.1% | XXX | XXX | XXX | $-2.18 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRedcare Pharmacy Valuation Multiples
Redcare Pharmacy trades at 0.4x EV/Revenue multiple, and 18.5x EV/EBITDA.
EV / Revenue (LTM)
Redcare Pharmacy Financial Valuation Multiples
As of April 18, 2026, Redcare Pharmacy has market cap of $1B and EV of $1B.
Equity research analysts estimate Redcare Pharmacy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Redcare Pharmacy has a P/E ratio of (31.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV (current) | $1B | XXX | $1B | XXX | XXX | XXX |
| EV/Revenue | 0.4x | XXX | 0.4x | XXX | XXX | XXX |
| EV/EBITDA | 18.5x | XXX | 21.4x | XXX | XXX | XXX |
| EV/EBIT | (104.6x) | XXX | (62.3x) | XXX | XXX | XXX |
| EV/Gross Profit | 1.8x | XXX | 1.8x | XXX | XXX | XXX |
| P/E | (31.6x) | XXX | (26.5x) | XXX | XXX | XXX |
| EV/FCF | (17.0x) | XXX | (13.8x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Redcare Pharmacy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Redcare Pharmacy Margins & Growth Rates
Redcare Pharmacy's revenue in the last 12 month grew by 14%.
Redcare Pharmacy's revenue per employee in the last FY averaged $1.3M, while opex per employee averaged $0.3M for the same period.
Redcare Pharmacy's rule of 40 is 16% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Redcare Pharmacy's rule of X is 37% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Redcare Pharmacy Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 14% | XXX | XXX | XXX |
| EBITDA Margin | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Growth | 50% | XXX | 52% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 16% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 37% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $1.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 19% | XXX | 19% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 3% | XXX | 3% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 0% | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 24% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Redcare Pharmacy Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Anhui Huaren Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Aldawaa Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Medplus Health Services | XXX | XXX | XXX | XXX | XXX | XXX |
| Selçuk Ecza | XXX | XXX | XXX | XXX | XXX | XXX |
| Yixintang Pharmaceutical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Redcare Pharmacy M&A Activity
Redcare Pharmacy acquired XXX companies to date.
Last acquisition by Redcare Pharmacy was on XXXXXXXX, XXXXX. Redcare Pharmacy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Redcare Pharmacy
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialRedcare Pharmacy Investment Activity
Redcare Pharmacy invested in XXX companies to date.
Redcare Pharmacy made its latest investment on XXXXXXXX, XXXXX. Redcare Pharmacy invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Redcare Pharmacy
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Redcare Pharmacy
| When was Redcare Pharmacy founded? | Redcare Pharmacy was founded in 2015. |
| Where is Redcare Pharmacy headquartered? | Redcare Pharmacy is headquartered in Netherlands. |
| How many employees does Redcare Pharmacy have? | As of today, Redcare Pharmacy has over 2K employees. |
| Is Redcare Pharmacy publicly listed? | Yes, Redcare Pharmacy is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of Redcare Pharmacy? | Redcare Pharmacy trades under RDC ticker. |
| When did Redcare Pharmacy go public? | Redcare Pharmacy went public in 2016. |
| Who are competitors of Redcare Pharmacy? | Redcare Pharmacy main competitors are Anhui Huaren Health, Aldawaa Medical Services, Medplus Health Services, Selçuk Ecza. |
| What is the current market cap of Redcare Pharmacy? | Redcare Pharmacy's current market cap is $1B. |
| What is the current revenue of Redcare Pharmacy? | Redcare Pharmacy's last 12 months revenue is $4B. |
| What is the current revenue growth of Redcare Pharmacy? | Redcare Pharmacy revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Redcare Pharmacy? | Current revenue multiple of Redcare Pharmacy is 0.4x. |
| Is Redcare Pharmacy profitable? | Yes, Redcare Pharmacy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Redcare Pharmacy? | Redcare Pharmacy's last 12 months EBITDA is $77M. |
| What is Redcare Pharmacy's EBITDA margin? | Redcare Pharmacy's last 12 months EBITDA margin is 2%. |
| What is the current EV/EBITDA multiple of Redcare Pharmacy? | Current EBITDA multiple of Redcare Pharmacy is 18.5x. |
| What is the current FCF of Redcare Pharmacy? | Redcare Pharmacy's last 12 months FCF is ($84M). |
| What is Redcare Pharmacy's FCF margin? | Redcare Pharmacy's last 12 months FCF margin is (2%). |
| What is the current EV/FCF multiple of Redcare Pharmacy? | Current FCF multiple of Redcare Pharmacy is (17.0x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.